CARLEY GOLDMAN: Open Payments
NPI 1013452457 · TREVOSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 40 payments from 13 companies in 2025. Trend: 2023 $935 · 2024 $1,117 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $178 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 4 | $81 |
| Novo Nordisk Inc | 4 | $80 |
| Lilly USA, LLC | 3 | $65 |
| Exact Sciences Corporation | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $41 |
| PFIZER INC. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: AIRSUPRA, GEMTESA, SPRAVATO, MOUNJARO, The Cologuard Plus Collection Kit, FARXIGA, JARDIANCE, GATTEX.
Industry payments across PA — which companies pay providers there.
